Bayer pharmaceuticals voluntarily recalled Baycol: a statin drug used to decrease cholesterol

 

Bayer AG Pharmaceuticals recalled Baycol August 2001

 
 

 

Bayer AG Pharmaceuticals
In 1863, eighteen years after opening his first company with Johann Friedrich Weskott, Friedrich Bayer established Bayer Pharmaceuticals and began a legacy of pioneering drug developments. Bayer AG, the manufacturer of Baycol, is one of the world's leading chemical companies.

Baycol's impact on Bayer
Bayer's pharmaceutical history is impressive, but in recent years the company has fallen behind. Several very promising drugs that Bayer had scheduled to release into the market have been postponed or cancelled. Baycol's recall has been especially disappointing to Bayer's investors because of the potential revenue that has been lost. Bayer expected sales of Baycol to reach $800 million this year. As a result Bayer was forced to lower its estimated revenue by over $570 million.

Baycol lawsuits
Lawyers began filing suit on behalf of victims suffering from Baycol side effects almost immediately after the withdrawal. The lawyers claim that Bayer knew Baycol caused severe Rhabdomyolysis and acted negligently in delaying the withdrawal of Baycol from the market.

 

Baycol Home

National Baycol Lawyers:

Local Baycol Lawyers:

Thornton & Naumes Law Firm

Baycol InfoCenter

Rhabdomyolysis

Statin Drugs

Baycol FAQs

Bayer AG Pharmaceuticals

Baycol letter to physicians May 2001

Baycol Recall letter August 2001

 

 

Send to a Friend || || Contact Us || Privacy Policy
baycol bayer ag pharmaceutical corner image